A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of this study is to investigate the effect of gastric pH changes induced by famotidine on the drug levels of BMS-986256.

Key facts

Study ID

NCT04941755

Run by

Bristol-Myers Squibb

People needed

22

Starts

2021-06-25

Expected to finish

2021-09-24

Last updated by the study team

2022-01-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy participants, defined as having no clinically significant deviations from normal in medical history
• Weight ≥ 50 kg and body mass index between 18.0 kg/m2 and 32.0 kg/m2, inclusive, at screening
• Normal renal function at screening

You may not qualify if…

• Any significant acute or chronic medical illness
• Current or recent gastrointestinal (GI) disease that could impact upon the absorption of study treatment
• Any major surgery within 4 weeks of study treatment administration
• Significant history of GI abnormalities
• Other protocol-defined inclusion/exclusion criteria apply

Where it is running

• PPD Development, LP — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.